Localized inflammation observed during severe COVID-19 has been linked with respiratory distress and is also associated with elevated levels of cytokines, such as interleukin 6 (IL-6) produced by T cells and inflammatory monocytes (15, 16). Here, IL6 is linked to COVID-19.